🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Microbot Medical Inc. (MBOT)
NASDAQ: MBOT · Real-Time Price · USD
0.6800
-0.0633 (-8.52%)
At close: Nov 20, 2026, 4:00 PM EST
0.6808
+0.0008 (0.12%)
After-hours: Nov 20, 2026, 7:59 PM EST

Microbot Medical Stock Forecast

MBOT's stock price has decreased by -64.58% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 4 analysts polled by S&P Global, Microbot Medical stock has a consensus rating of "Strong Buy" and an average price target of $5.00. The average 1-year stock price forecast is 635.29% higher than the current stock price, while the lowest is $2.00 (+194.12%) and the highest is $12 (+1,664.71%).

Price Target: $5.00 (+635.29%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$2.00$5.00$3.00$12
Change+194.12%+635.29%+341.18%+1664.7%

Analyst Ratings

The average analyst rating for Microbot Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy333333
Buy000011
Hold000000
Sell000000
Strong Sell000000
Total333344

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
B. Riley Securities
B. Riley Securities
Buy
Maintains
$4 → $3
BuyMaintains$4 → $3+341.18%Nov 19, 2026
Citizens JMP
Citizens JMP
Buy
Maintains
$2.5 → $2
BuyMaintains$2.5 → $2+194.12%Nov 17, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$12
BuyReiterates$12+1,664.71%Oct 28, 2026
Lucid Capital
Lucid Capital
Buy
Maintains
$4 → $3
BuyMaintains$4 → $3+341.18%Sep 25, 2026
Titan Partners
Titan Partners
Buy
Reiterates
$5.5
BuyReiterates$5.5+708.82%Apr 13, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
1.20M
Revenue Next Year
5.14M
from 1.20M
Increased by 328.60%
EPS This Year
-0.32
from -0.29
EPS Next Year
-0.34
from -0.32
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026E
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
-----1.20M
Operating Income
-11.36M-13.28M-9.86M-11.63M-14.74M-23.80M
Net Income
-11.31M-13.17M-10.74M-11.44M-13.14M-21.47M
EPS
-----0.29-0.32
Free Cash Flow
-----13.11M-25.00M
No. Analysts
-----3
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High1.9M
Avg1.2M
Low800,000

Revenue Growth

Revenue Growth20272028
High
700.9%
Avg
328.6%
Low
87.7%

EPS Forecast

EPS202620272028
High-0.30
Avg-0.32
Low-0.34

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-